All In MedTech

Device Trial Radar · NCT02455895

Efficacy of iLid Cleanser (Avenova) Versus Vehicle on Ocular Skin Flora

A Multicenter Randomized, Double-Masked Study Comparing the Efficacy of Novabay iLid Cleanser Versus Vehicle on Ocular Skin Flora

Last checked: Nov 20, 2026Latest source record: May 28, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

100

Planned (sponsor's estimate)

Start

May 2015

Primary completion

Jan 2016

Study completion May 2016

Sponsor

Lead sponsor
NovaBay Pharmaceuticals, Inc.Not on our public-company list
Sponsor type
Industry
First posted
May 28, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Supportive care
Who can join
All sexes, from 6 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is designed to evaluate the effect of Novabay iLid Cleanser, as compared to its Vehicle, on the ocular skin flora. In the pre-randomization phase, subjects will receive a single application of open-label NovaBay iLid Cleanser. In the randomization phase of Stages 1 and 2, subjects will self-treat with masked Investigational Product twice daily for ten (10) days.

Conditions

  • Sebaceous Gland Diseases
  • Blepharitis

Interventions

  • iLid CleanserDevice

    Application of iLid Cleanser to reduce bacterial load on the lid and lash margins

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Microbiological efficacyTime frame: 20 minutes after application of test article

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Ophthalmic Research Consultants of Arizona

    Phoenix, Arizona · Recruiting

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.